T622-0531 Screening compound: 9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane

T622-0531 Screening compound: 9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane
T622-0531 Screening compound: 9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane alternative view

Chemical Structure Depiction of ChemDiv screening compound T622-0531
9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T622-0531

Molecular Formula

C23H34N4O2 (C23 H34 N4 O2)

Compound Name

9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane

IUPAC name

9-cyclobutanecarbonyl-4-[4-(pyridin-2-yl)piperazin-1-yl]-1-oxa-9-azaspiro[5.5]undecane

SMILES

O=C(C1CCC1)N(CC1)CCC1(C1)OCCC1N(CC1)CCN1c1ncccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

398.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.160

Distribution Coefficient, logD

2.011

Water Solubility, LogSw

-2.27

Polar Surface Area

38.877

Acid Dissociation Constant (pKa)

23.62

Base Dissociation Constant (pKb)

7.01

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

73.91

T622-0531 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T622-0531 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T622-0531?
Check Price and Availability of T622-0531, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T622-0531 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T622-0531
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T622-0531
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T622-0531 available by request